Log in to save to my catalogue

A Combination of Olanzapine and Samidorphan in Adults with Schizophrenia and Bipolar I Disorder: Ove...

A Combination of Olanzapine and Samidorphan in Adults with Schizophrenia and Bipolar I Disorder: Ove...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2727651313

A Combination of Olanzapine and Samidorphan in Adults with Schizophrenia and Bipolar I Disorder: Overview of Clinical Data

About this item

Full title

A Combination of Olanzapine and Samidorphan in Adults with Schizophrenia and Bipolar I Disorder: Overview of Clinical Data

Publisher

New York, USA: Cambridge University Press

Journal title

CNS spectrums, 2021-04, Vol.26 (2), p.170-170

Language

English

Formats

Publication information

Publisher

New York, USA: Cambridge University Press

More information

Scope and Contents

Contents

Olanzapine effectively treats schizophrenia and bipolar I disorder (BD-I); however, its use is hindered by significant weight gain. A combination of olanzapine and samidorphan (OLZ/SAM) is in development to provide the efficacy of olanzapine while mitigating olanzapine-associated weight gain through opioid-receptor blockade. Here, we summarize OLZ/...

Alternative Titles

Full title

A Combination of Olanzapine and Samidorphan in Adults with Schizophrenia and Bipolar I Disorder: Overview of Clinical Data

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2727651313

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2727651313

Other Identifiers

ISSN

1092-8529

E-ISSN

2165-6509

DOI

10.1017/S1092852920002771

How to access this item